Nagoya City University Psychiatry

sitemap

Anxiety Disorders

Ogawa S, Furukawa TA, Nakano Y, Funayama T, Watanabe N, Noguchi Y & Sasaki M (in press) Interoceptive hypersensitivity as prognostic factor among patients with panic disorder who have received cognitive behavioral therapy. Journal of Beahvior Therapy and Experimental Psychiatry.
Furukawa TA, Watanabe N & Omori IM (2010) What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD. In Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V. (eds Goldberg D, Kendler KS, Sirovatka P & Regier DA), pp. 71-104. Arlington, VA: American Psychiatric Association.
Furukawa TA, Chen J, Watanabe N, Nakano Y, Ietsugu T, Ogawa S, Funayama T & Noda Y (2009) Videotaped experiments to drop safety behaviors and self-focused attention for patients with social anxiety disorder: Do they change subjective and objective evaluations of anxiety and performance? Journal of Behavior Therapy and Experimental Psychiatry, 40, 202-210.
Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, Etschel E, Engel RR & Leucht S (2009) Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depression and Anxiety, 26, 922-929.
Watanabe N, Churchill R & Furukawa TA (2009) Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database of Systematic Reviews, CD005335.
Tsuchiya M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T, Kikkawa T & Kessler RC (2009) Lifetime comorbidities between phobic disorders and major depression in Japan: results from the World Mental Health Japan 2002-2004 Survey. Depression and Anxiety.
Faravelli C, Furukawa TA & Truglia E (2009) Panic disorder. In Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V. (eds Andrews G, Charney DS, Sirovatka PJ & Regier DA), pp. 31-58. Arlington, VA: American Psychiatric Association.
Chen J, Tsuchiya M, Kawakami N & Furukawa TA (2009) Non-fearful vs fearful panic attacks: A general population study from the National Comorbidity Survey. Journal of Affective Disorders, 112, 273-278.
Nakano Y, Lee K, Noda Y, Ogawa S, Kinoshita Y, Funayama T, Watanabe N, Chen J, Noguchi Y & Furukawa TA (2008) Cognitive-behavior therapy for Japanese patients with panic disorder: acute phase and one-year follow-up results. Psychiatry and Clinical Neurosciences, 62, 313-321.
Nakaaki S, Murata Y & Furukawa TA (2008) Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Psychiatry and Clinical Neurosciences, 62, 370.
Kinoshita Y, Chen J, Rapee RM, Bogels S, Schneier FR, Choy Y, Kwon JH, Liu X, Schramm E, Chavira DA, Nakano Y, Watanabe N, Ietzugu T, Ogawa S, Emmelkamp P, Zhang J, Kingdon D, Nagata T & Furukawa TA (2008) Cross-cultural study of conviction subtype Taijin Kyofu: proposal and reliability of Nagoya-Osaka diagnostic criteria for social anxiety disorder. Journal of Nervous and Mental Disease, 196, 307-313.
Watanabe N, Churchill R & Furukawa TA (2007) Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry, 7, 18.
Omori IM, Murata Y, Yamanishi T, Nakaaki S, Akechi T, Mikuni M & Furukawa TA (2007) The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptoms. Journal of Psychiatric Research, 41, 776-784.
Noda Y, Nakano Y, Lee K, Ogawa S, Kinoshita Y, Funayama T, Watanabe N, Chen J, Noguchi Y, Kataoka M, Suzuki M & Furukawa TA (2007) Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. BMC Psychiatry, 7, 70.
Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T & Galan C (2007) Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. Journal of Psychopharmacology, 21, 774-782.
Ietsugu T, Sukigara M & Furukawa TA (2007) Evaluation of diagnostic criteria for panic attack using item response theory: Findings from the National Comorbidity Survey in USA. Journal of Affective Disorders, 104, 197-201.
Furukawa TA, Watanabe N, Omori IM & Churchill R (2007) Can pill placebo augment cognitive-behavior therapy for panic disorder? BMC Psychiatry, 7, 73.
Furukawa T, Watanabe N & Churchill R (2007) Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews, CD004364.
Chen J, Nakano Y, Ietzugu T, Ogawa S, Funayama T, Watanabe N, Noda Y & Furukawa TA (2007) Group cognitive behavior therapy for Japanese patients with social anxiety disorder: preliminary outcomes and their predictors. BMC Psychiatry, 7, 69.
Furukawa TA, Watanabe N & Churchill R (2006) Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. British Journal of Psychiatry, 188, 305-312.
Lee K, Noda Y, Nakano Y, Ogawa S, Kinoshita Y, Funayama T & Furukawa TA (2006) Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: specificity and effectiveness. BMC Psychiatry, 6, 32.
Eguchi M, Noda Y, Nakano Y, Kanai T, Yamamoto I, Watanabe N, Lee K, Ogawa S, Ietsugu T, Sasaki M, Chen J & Furukawa TA (2005) Quality of life and social role functioning in Japanese patients with panic disorder. Journal of Nervous and Mental Disease, 193, 686-689.
Sakurai A, Nagata T, Harai H, Yamada H, Mohri I, Nakano Y, Noda Y, Ogawa S, Lee K & Furukawa TA (2005) Is "relationship fear" unique to Japan? Symptom factors and patient clusters of social anxiety disorder among the Japanese clinical population. Journal of Affective Disorders, 87, 131-137.
Yamamoto I, Nakano Y, Watanabe N, Noda Y, Furukawa TA, Kanai T, Takashio O, Koda R, Otsubo T & Kamijima K (2004) Cross-cultural evaluation of the Panic Disorder Severity Scale in Japan. Depression and Anxiety, 20, 17-22.
Furukawa TA (2003) Effectiveness: the treatment of panic disorder in the real world. Current Opinion in Psychiatry, 16, 45-48.
Inada T, Nozaki S, Inagaki A & Furukawa TA (2003) Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan. Human Psychopharmacology, 18, 483-487.